Regeneron Pharmaceuticals

IRS: 133444607
REGN
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation.

Founded
1988 (33 years)
CEO
Leonard S. Schleifer
Investor RelationsSEC
Revenue
8 billion (2020)

Want to see more? Sign up!